Search
Filters
Clear All
  • 2
  • 11
  • 49

Phase

  • 7
  • 3
  • 16
  • 2
  • 16
  • 1
  • 17
  • 61
  • 3

Found 62 site-public-contact trials

A listing of site-public-contact medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

A Randomized Phase III Study to Evaluate Benefits of Autologous Stem Cell Transplant in Patients with Peripheral T Cell Lymphoma that Achieved a First Complete Remission (CR1) Following Induction Therapy (PTCL-STAT)

U
Utpal Dave, MD
18 years - 75 years
All genders
Phase 3
Primary: To demonstrate improvement in progression free survival (PFS) in the autologous stem cell transplant (ASCT) arm compared to the observation arm. Secondary: -To assess difference in overall survival (OS) between the observation and autologous stem cell transplant (ASCT) arm. -To evaluate the differences in study intervention benefit for PFS …
Learn More

Study on Safety and Tolerability of Investigational Medication in Advanced Solid Tumors (types of cancer that form solid masses)

N
Nabil Adra, MD
15 years - 100 years
All genders
Phase 1
This study investigates the safety and tolerability of an investigational medication in people with advanced solid tumors. Advanced solid tumors are cancers that have spread and are difficult to treat. The purpose of this study is to find out if the investigational medication is safe and to determine the best …
Learn More

Study of Investigational Combinations for Prostate Cancer

N
Nabil Adra, MD
18 years - 100 years
Male
Phase 2
This study investigates the effects of combining two investigational medications for treating prostate cancer that has spread and is resistant to standard treatments. The study focuses on adult male patients with prostate cancer that shows positive results on a specific type of scan. The purpose is to find out how …
Learn More

Research on Medicine for Pancreatic and Lung Cancer

A
Anita Turk, MD
18 years - 100 years
All genders
This study investigates the safety and effects of an investigational medication in combination with other agents for patients with pancreatic or non-small cell lung cancer. These cancers are being studied because they have specific genetic changes called MTAP loss and RAS mutation. The purpose is to see how the investigational …
Learn More

Study of Investigational Medication in Combination with Other Treatments for Extensive Stage Small-Cell Lung Cancer

M
Misty D. Shields, MD, PhD
18 years - 100 years
All genders
Phase 3
This study investigates the effects of an investigational medication combined with other treatments for extensive stage small-cell lung cancer (ES-SCLC). ES-SCLC is a type of lung cancer that has spread extensively within the body. The purpose is to see if the investigational medication can improve overall survival when used with …
Learn More

Investigating the Safety of an Investigational Treatment for a Type of Cancer Affecting White Blood Cells

H
Huda Salman
18 years - 100 years
All genders
Phase 1
This study investigates the safety of an investigational treatment using special immune cells called CAR-T cells for people with certain B cell cancers. B cell malignancies are cancers that affect a type of white blood cell. The study includes participants whose cancer has returned or not responded to previous treatments. …
Learn More

Study of Investigational Medication for KRAS Mutant Solid Tumors

G
Greg Durm, MD
18 years - 100 years
All genders
Phase 1/2
This study investigates an investigational medication for people with solid tumors that have specific KRAS mutations. These mutations are changes in a gene that can affect how cells grow. The purpose of this study is to understand if the investigational medication is safe and can be tolerated by patients with …
Learn More

Investigating Safety and Effectiveness of an Investigational Medication for Low-grade Upper Tract Urothelial Cancer

H
Hristos Kaimakliotis, MD
18 years - 100 years
All genders
Phase 1/2
This study investigates the safety and effectiveness of an investigational medication for adults with low-grade upper tract urothelial carcinoma (LG-UTUC). LG-UTUC is a type of cancer that occurs in the urinary system, specifically the upper part of the ureter and kidney. The study will involve a safety lead-in period for …
Learn More

Investigation of an Investigational Medication for Advanced Solid Tumors with FGFR3 Alterations

T
Tareq Salous
18 years - 100 years
All genders
Phase 1
This study investigates the safety, side effects, and effectiveness of an investigational medication in treating advanced solid tumors with FGFR3 alterations, including metastatic urothelial cancer. FGFR3 is a gene that, when altered, can contribute to the growth of cancer cells. The purpose of this study is to understand how the …
Learn More

Investigating Additional Treatments for Infant Blood Cancer

A
Amanda J. Saraf, DO
1 year or below
All genders
Phase 2
This study investigates the addition of investigational medication and investigational immunotherapy to the usual chemotherapy for infants with newly diagnosed acute lymphoblastic leukemia (ALL). ALL is a type of cancer where the bone marrow makes too many immature lymphocytes (a type of white blood cell). In this study, the researchers …
Learn More
51 - 60 of 62